08 April 2019
Visiongain has launched a new pharma report Collagen Pharma Market Report 2019-2029 : Revenue Prospects for Source, Product, and Application.
Currently, collagen has become in demand ingredient towards healthy foods development. Collagen productions in the body decline with age and bad diet. As collagen injection is not a preference to most people, the best way to gain collagen is through diet. Consequently, collagen has been blended together in a variety of foods and beverages products. Furthermore, it has been applied as protein dietary supplements, carriers in the meat processing, edible film and coatings of products, and food additive to enhance products’ quality.
The lead analyst of the report commented "Demand for premium grade collagen for surgical procedures, wound dressing, and drug delivery mechanisms is expected to drive the market within the forecast period. Marine collagen is expected to grow at a fast pace in the forecast period. Marine collagens are regarded as superior collagens as they are absorbed much more efficiently into the body. The market in the Asia Pacific is expected to register comparatively faster growth in terms of revenue over the next 10 years and this is attributed to increasing demand for beauty products and health supplements in the region."
Leading companies featured in the report include Advanced BioMatrix, Inc., Collagen Matrix, Collagen Solution Plc, Cologenesis HealthCare Pvt. Ltd., CONNOILS LLC, Croda International Plc., JBS S.A., Koninklijke DSM N.V., and other companies.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 20 7549 9987.
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
29 July 2021
Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.
21 July 2021
Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.
20 July 2021
Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their customers’ operations and gaining the maximum share of their outsourcing budgets, driven by the willingness of pharma to reduce the number of outsourcers they use.